Literature DB >> 32393049

Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components.

Mateo Ondrussek-Sekac1, Diana Navas-Carrillo2, Esteban Orenes-Piñero1.   

Abstract

In chronic kidney disease, as in many other diseases, dysbiosis of intestinal microbiota has been reported as a disturbance or imbalance of the normal microbiome content that could disrupt the symbiotic relationship between the host and associated microbes, a disruption that can result in diseases. The disruption of gut barrier function allows the translocation of endotoxins and bacterial metabolites to the organism, thus contributing to uremic toxicity, inflammation and progression of chronic kidney disease. Increased intake of some nutrients and different nutritional strategies have been proposed to modulate gut microbiota, thus offering the opportunity for therapeutic interventions modifying the diet, decreasing uremic toxins production, increasing toxin excretion and finally modifying the normal microbiome content. The use of probiotics, prebiotics and low protein diets, among other approaches, could also improve this imbalance and/or decrease permeability of the intestinal barrier. In this review, the link between nutrients, microbiota and uremic toxins with chronic kidney disease progression has been studied thoroughly. Furthermore, this review outlines potential mechanisms of action and efficacy of probiotics, prebiotics and low protein diets as a new chronic kidney disease management tool.

Entities:  

Keywords:  Chronic kidney disease; dietary components; gut microbiota; inflammation; uremic toxins

Mesh:

Substances:

Year:  2020        PMID: 32393049     DOI: 10.1080/10408398.2020.1761771

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  7 in total

1.  Fecal microbiota transplantation for membranous nephropathy.

Authors:  Guanzhou Zhou; Jiaqi Zeng; Lihua Peng; Lei Wang; Wei Zheng; Yunsheng Yang
Journal:  CEN Case Rep       Date:  2021-01-02

2.  Effects of Microbiota-Driven Therapy on Circulating Indoxyl Sulfate and P-Cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Li Chen; Junhe Shi; Xiaojuan Ma; Dazhuo Shi; Hua Qu
Journal:  Adv Nutr       Date:  2022-08-01       Impact factor: 11.567

3.  Processed Plant-Based Foods for CKD Patients: Good Choice, but Be Aware.

Authors:  Claudia D'Alessandro; Jason Pezzica; Carolina Bolli; Alice Di Nicola; Azzurra Falai; Domenico Giannese; Adamasco Cupisti
Journal:  Int J Environ Res Public Health       Date:  2022-05-30       Impact factor: 4.614

Review 4.  Nutritional Status in Peritoneal Dialysis: Nutritional Guidelines, Adequacy and the Management of Malnutrition.

Authors:  Thomas Kiebalo; Jacqueline Holotka; Ireneusz Habura; Krzysztof Pawlaczyk
Journal:  Nutrients       Date:  2020-06-08       Impact factor: 5.717

5.  Higher dietary inflammatory index is associated with increased all-cause mortality in adults with chronic kidney disease.

Authors:  Li-Jun Yan; Fei-Ran Zhang; Chan-Shan Ma; Yang Zheng
Journal:  Front Nutr       Date:  2022-07-22

Review 6.  Crosstalk between gut microbiota and renal ischemia/reperfusion injury.

Authors:  Peng Huang; Jianwei Cao; Jingyi Chen; Yanrong Luo; Xiaofang Gong; Chengyi Wu; Yu Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-05       Impact factor: 6.073

7.  Effectiveness of Microecological Preparations for Improving Renal Function and Metabolic Profiles in Patients With Chronic Kidney Disease.

Authors:  Jiaxing Tan; Huan Zhou; Jiaxin Deng; Jiantong Sun; Xiaoyuan Zhou; Yi Tang; Wei Qin
Journal:  Front Nutr       Date:  2022-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.